Cargando…
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
PURPOSE: The CellSearch® system has been used to identify circulating tumor cells (CTCs) in cerebrospinal fluid (CSF) to diagnose leptomeningeal metastasis (LM) in patients with epithelial cancers. Using this system, we prospectively explored sequential CSF CTC enumeration in patients with LM from H...
Autores principales: | Malani, Rachna, Fleisher, Martin, Kumthekar, Priya, Lin, Xuling, Omuro, Antonio, Groves, Morris D., Lin, Nancy U., Melisko, Michelle, Lassman, Andrew B., Jeyapalan, Suriya, Seidman, Andrew, Skakodub, Anna, Boire, Adrienne, DeAngelis, Lisa M., Rosenblum, Marc, Raizer, Jeffrey, Pentsova, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438284/ https://www.ncbi.nlm.nih.gov/pubmed/32506369 http://dx.doi.org/10.1007/s11060-020-03555-z |
Ejemplares similares
-
LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY
por: Kumthekar, Priya, et al.
Publicado: (2019) -
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis
por: Wijetunga, N Ari, et al.
Publicado: (2021) -
Advances in the diagnosis, evaluation, and management of leptomeningeal disease
por: Sener, Ugur, et al.
Publicado: (2021) -
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
por: Pentsova, Elena I., et al.
Publicado: (2016) -
SPCR-02 NEUROCOGNITIVE FUNCTION IN PATIENTS WITH LEPTOMENINGEAL METASTASIS TREATED WITH PROTON CRANIOSPINAL IRRADIATION
por: Correa, Denise, et al.
Publicado: (2022)